Skip to main content
HairCited

スピロノラクトン 図

5 査読済み研究からの図表

すべて L-システイン MSM PRP療法 オメガ3脂肪酸 カフェイン（外用） ケラチン コラーゲン スピロノラクトン セレン デュタステリド ビタミンB12 ビタミンD フィナステリド マイクロニードリング ミノキシジル ローズマリーオイル 亜鉛 低出力レーザー治療 鉄
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Fig. 5. Summary of evidence for the use of combination treatment of topical minoxidil in male and female androgenetic alopecia (Varothai and Bergfeld, 2014)
Figure 7

A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy.

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.

Figure 3
Figure 3

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Figure 4
Figure 4

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Figure 5
Figure 5

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.
Figure 6

Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …